Fanny Robbesyn

861 total citations
15 papers, 707 citations indexed

About

Fanny Robbesyn is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Fanny Robbesyn has authored 15 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Fanny Robbesyn's work include Atherosclerosis and Cardiovascular Diseases (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Fanny Robbesyn is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Fanny Robbesyn collaborates with scholars based in France, Austria and Italy. Fanny Robbesyn's co-authors include Robert Salvayre, Anne Nègre‐Salvayre, Giuseppe Poli, Gabriella Leonarduzzi, Nathalie Augè, Otília V. Vieira, Virginie Garcia, Dani Nazzal, Jean‐Claude Thiers and Carine Duval and has published in prestigious journals such as Blood, The FASEB Journal and Free Radical Biology and Medicine.

In The Last Decade

Fanny Robbesyn

15 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fanny Robbesyn France 12 292 178 175 106 73 15 707
Eunsil Hahm United States 16 373 1.3× 154 0.9× 200 1.1× 38 0.4× 101 1.4× 31 1.1k
L. J. Lewis United States 10 309 1.1× 181 1.0× 193 1.1× 261 2.5× 92 1.3× 15 878
Christine L. Webb United States 11 260 0.9× 220 1.2× 125 0.7× 30 0.3× 74 1.0× 16 643
Mysore P. Ramprasad United States 13 395 1.4× 318 1.8× 556 3.2× 121 1.1× 133 1.8× 18 1.2k
Maciej Małecki Poland 14 280 1.0× 73 0.4× 78 0.4× 63 0.6× 30 0.4× 83 732
Ziyang Cui China 3 266 0.9× 94 0.5× 254 1.5× 22 0.2× 57 0.8× 4 668
Heather F. McMurray United States 7 146 0.5× 80 0.4× 131 0.7× 58 0.5× 95 1.3× 8 502
Yasuhiko Kiyozuka Japan 21 532 1.8× 142 0.8× 65 0.4× 51 0.5× 122 1.7× 56 1.1k
Annukka M. Kivelä Finland 19 751 2.6× 186 1.0× 121 0.7× 38 0.4× 95 1.3× 27 1.1k
Tatsuo Katagishi Japan 12 234 0.8× 73 0.4× 93 0.5× 51 0.5× 137 1.9× 16 952

Countries citing papers authored by Fanny Robbesyn

Since Specialization
Citations

This map shows the geographic impact of Fanny Robbesyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny Robbesyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny Robbesyn more than expected).

Fields of papers citing papers by Fanny Robbesyn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanny Robbesyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny Robbesyn. The network helps show where Fanny Robbesyn may publish in the future.

Co-authorship network of co-authors of Fanny Robbesyn

This figure shows the co-authorship network connecting the top 25 collaborators of Fanny Robbesyn. A scholar is included among the top collaborators of Fanny Robbesyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanny Robbesyn. Fanny Robbesyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Dulucq, Stéphanie, Françoise Rigal‐Huguet, Franck E. Nicolini, et al.. (2023). Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment‐free remission period after imatinib discontinuation: Results of the French Nilo post‐STIM study. British Journal of Haematology. 201(6). 1116–1124. 8 indexed citations
2.
Dulucq, Stéphanie, Gabriel Étienne, Stéphane Morisset, et al.. (2019). Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line. Annals of Hematology. 98(5). 1159–1168. 1 indexed citations
3.
Étienne, Gabriel, Stéphanie Dulucq, Françoise Huguet, et al.. (2019). Incidence and outcome of BCR‐ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors. Cancer Medicine. 8(11). 5173–5182. 15 indexed citations
4.
5.
Renault, Marie‐Ange, Fanny Robbesyn, Candice Chapouly, et al.. (2013). Hedgehog-Dependent Regulation of Angiogenesis and Myogenesis Is Impaired in Aged Mice. Arteriosclerosis Thrombosis and Vascular Biology. 33(12). 2858–2866. 27 indexed citations
6.
Renault, Marie‐Ange, Fanny Robbesyn, Patricia Réant, et al.. (2010). Osteopontin Expression in Cardiomyocytes Induces Dilated Cardiomyopathy. Circulation Heart Failure. 3(3). 431–439. 48 indexed citations
7.
Filipe, Cédric, Barbara Garmy‐Susini, Fanny Robbesyn, et al.. (2008). Estrogen-Stimulated Endothelial Repair Requires Osteopontin. Arteriosclerosis Thrombosis and Vascular Biology. 28(12). 2131–2136. 17 indexed citations
8.
Leonarduzzi, Gabriella, Paola Gamba, Barbara Sottero, et al.. (2005). Oxysterol-induced up-regulation of MCP-1 expression and synthesis in macrophage cells. Free Radical Biology and Medicine. 39(9). 1152–1161. 72 indexed citations
9.
Sottero, Barbara, Paola Gamba, Fanny Robbesyn, et al.. (2005). Expression and synthesis of TGFβ1 is induced in macrophages by 9‐oxononanoyl cholesterol, a major cholesteryl ester oxidation product. BioFactors. 24(1-4). 209–216. 19 indexed citations
10.
Robbesyn, Fanny, Nathalie Augè, Cécile Vindis, et al.. (2005). High-Density Lipoproteins Prevent the Oxidized Low-Density Lipoprotein–Induced Endothelial Growth Factor Receptor Activation and Subsequent Matrix Metalloproteinase-2 Upregulation. Arteriosclerosis Thrombosis and Vascular Biology. 25(6). 1206–1212. 58 indexed citations
11.
Robbesyn, Fanny, Robert Salvayre, & Anne Nègre‐Salvayre. (2004). Dual Role of Oxidized LDL on the NF-KappaB Signaling Pathway. Free Radical Research. 38(6). 541–551. 123 indexed citations
12.
Leonarduzzi, Gabriella, Fanny Robbesyn, & Giuseppe Poli. (2004). Signaling kinases modulated by 4-hydroxynonenal. Free Radical Biology and Medicine. 37(11). 1694–1702. 117 indexed citations
13.
14.
Nègre‐Salvayre, Anne, Nathalie Augè, Carine Duval, et al.. (2002). [5] Detection of intracellular reactive oxygen species in cultured cells using fluorescent probes. Methods in enzymology on CD-ROM/Methods in enzymology. 352. 62–71. 83 indexed citations
15.
Vacaresse, Nathalie, Otília V. Vieira, Fanny Robbesyn, et al.. (2001). Phenolic antioxidants trolox and caffeic acid modulate the oxidized LDL‐induced EGF‐receptor activation. British Journal of Pharmacology. 132(8). 1777–1788. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eunsil Hahm Breakdown of academic impact, for papers by L. J. Lewis Breakdown of academic impact, for papers by Christine L. Webb Breakdown of academic impact, for papers by Mysore P. Ramprasad Breakdown of academic impact, for papers by Maciej Małecki Breakdown of academic impact, for papers by Ziyang Cui Breakdown of academic impact, for papers by Heather F. McMurray Breakdown of academic impact, for papers by Yasuhiko Kiyozuka Breakdown of academic impact, for papers by Annukka M. Kivelä Breakdown of academic impact, for papers by Tatsuo Katagishi
Rankless by CCL
2026